Strategy Asset Managers LLC Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Strategy Asset Managers LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 269.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,755 shares of the healthcare conglomerate's stock after purchasing an additional 7,113 shares during the quarter. Strategy Asset Managers LLC's holdings in UnitedHealth Group were worth $5,703,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $27,000. Macroview Investment Management LLC boosted its stake in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at about $31,000. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after buying an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC raised its stake in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock valued at $32,000 after buying an additional 18 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Up 3.1 %

Shares of NYSE:UNH traded up $17.62 during trading on Wednesday, reaching $594.62. The company's stock had a trading volume of 1,909,052 shares, compared to its average volume of 3,871,303. The stock has a market capitalization of $547.22 billion, a PE ratio of 37.59, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The firm's 50 day simple moving average is $582.31 and its two-hundred day simple moving average is $551.25. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to analysts' expectations of $99.14 billion. During the same period in the previous year, the company earned $6.56 EPS. The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.41%. UnitedHealth Group's payout ratio is currently 54.72%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on UNH. Royal Bank of Canada dropped their price objective on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a report on Wednesday, October 16th. KeyCorp started coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They set an "overweight" rating and a $675.00 price objective for the company. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. Truist Financial reissued a "buy" rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Finally, Stephens lowered their price target on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.